EnPlusOne Biosciences provides innovative solutions for emerging RNA therapeutics.
EnPlusOne Biosciences has raised $10.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2025.
EnPlusOne Biosciences's investors include Coatue, Breakout Ventures, Northpond Ventures.
EnPlusOne Biosciences is headquartered in Watertown, United States.
EnPlusOne Biosciences provides innovative solutions for emerging RNA therapeutics.
EnPlusOne Biosciences is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EnPlusOne Biosciences — Funding & Investors." VCBacked, February 19, 2025, https://www.vcbacked.co/company/enplusone-biosciences. Accessed July 20, 2026.
VCBacked. (2025). EnPlusOne Biosciences — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/enplusone-biosciences
{{cite web |title=EnPlusOne Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/enplusone-biosciences |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated